| Title | Parties | Law Firm | Date | Gov Law | |
| Jefferies Global Healthcare and Life Science REIT Conference Presentation April 2013 |
 SABRA HEALTH CARE REIT, INC.
Genesis HealthCare LLC
National Association of Real Estate Investment Trusts
NON-GAAP FINANCIAL
Operations (FFO), Adjusted Funds
Sun Healthcare Group, Inc
| Unavailable | 4/13 | Unavailable |
|
| RXi Pharmaceuticals Reports |
RXI PHARMACEUTICALS CORP
Full Year 2012 Financial
OPKO Health, Inc
RXi Pharmaceuticals
| Unavailable | 3/13 | Unavailable |
|
| INCENTIVE STOCK OPTION AGREEMENT UNDER THE AEGERION PHARMACEUTICALS, INC. 2010 STOCK OPTION AND INCENTIVE PLAN |
AEGERION PHARMACEUTICALS, INC.
AEGERION PHARMACEUTICALS, INC
| Unavailable | 3/13 | Unavailable |
|
| SUPPLEMENTAL AGREEMENT TO SHARE TRANSFER CONTRACT OF SHAANXI WEINAN HUAREN PHARMACEUTICALS CO., LTD. BY AND BETWEEN SHAANXI AOXING PHARMACEUTICALS CO., LTD. AND FORMER SHAREHOLDERS OF SHAANXI WEINAN HUAREN PHARMACEUTICALS CO., LTD |
BIOSTAR PHARMACEUTICALS, INC.
SHAANXI AOXING PHARMACEUTICALS CO, LTD
SHAANXI WEINAN HUAREN PHARMACEUTICALS CO, LTD
| Unavailable | 3/13 | Unavailable |
|
| Sucampo Pharmaceuticals, Inc. Reports |
SUCAMPO PHARMACEUTICALS, INC.
BETHESDA, Md--(BUSINESS WIRE)--March 13, 2013--Sucampo Pharmaceuticals, Inc
| Unavailable | 3/13 | Unavailable |
|
| PROGENICS PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND YEAR-END 2012 FINANCIAL RESULTS |
PROGENICS PHARMACEUTICALS INC
Progenics Pharmaceuticals, Inc
QUARTER AND YEAR-END 2012 FINANCIAL
Salix Pharmaceuticals
| Unavailable | 3/13 | Unavailable |
|
| INTEGRATED ENVIRONMENTAL TECHNOLOGIES, LTD. ANNOUNCES THAT EXCELYTE® IS EFFECTIVE AGAINST DRUG RESISTANT BACTERIA CONTAMINATING HEALTHCARE FACILITIES |
INTEGRATED ENVIRONMENTAL TECHNOLOGIES, LTD.
INTEGRATED ENVIRONMENTAL TECHNOLOGIES, LTD
OTC Bulletin Board
| Unavailable | 3/13 | Unavailable |
|
| ACURA PHARMACEUTICALS' UNIVERSAL SHELF REGISTRATION STATEMENT DECLARED EFFECTIVE |
ACURA PHARMACEUTICALS, INC
| Unavailable | 3/13 | Unavailable |
|
| AMAG PHARMACEUTICALS 2012 Financial Results |
AMAG PHARMACEUTICALS INC.
AMAG PHARMACEUTICALS 2012 Financial
| Unavailable | 3/13 | Unavailable |
|
| Synergy Pharmaceuticals to Present Study Results from Plecanatide Phase IIb/III Trial in Late-Breaking Clinical Abstract at Digestive Disease Week 2013 |
SYNERGY PHARMACEUTICALS, INC.
Synergy Pharmaceuticals, Inc
| Unavailable | 3/13 | Unavailable |
|
| Rotech Healthcare Reaches Agreement in Principle with Its Major Debtholders On Debt Reduction and Restructuring |
ROTECH HEALTHCARE INC
| Foley Lardner | 3/13 | Unavailable |
|
| Genesis HealthCare LLC and Subsidiaries Consolidated Financial Statements December 31, 2012 |
SABRA HEALTH CARE REIT, INC.
Consolidated Financial
Genesis HealthCare LLC
| Unavailable | 3/13 | Unavailable |
|
| Ligand Signs Global License Agreement with Spectrum Pharmaceuticals for Captisol-Enabled® Melphalan |
LIGAND PHARMACEUTICALS INC
Ligand Pharmaceuticals Incorporated
Spectrum Pharmaceuticals, Inc
| Unavailable | 3/13 | Unavailable |
|
| ANACOR PHARMACEUTICALS REPORTS 2012 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS |
ANACOR PHARMACEUTICALS INC
Anacor Pharmaceuticals
YEAR-END FINANCIAL
| Unavailable | 3/13 | Unavailable |
|
| Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results and Recent Highlights Sunesis to Host Conference Call Today at 11:00AM Eastern Time |
SUNESIS PHARMACEUTICALS INC
Argot Partners
Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial
Sunesis Pharmaceuticals, Inc
| Unavailable | 3/13 | Unavailable |
|
| Peter W. Schineller Joins Alexza Pharmaceuticals as Senior Vice President and Chief Commercial Officer |
ALEXZA PHARMACEUTICALS INC.
Alexza Pharmaceuticals, Inc
Peter W Schineller Joins Alexza Pharmaceuticals
| Unavailable | 3/13 | Unavailable |
|
| FOR IMMEDIATE RELEASE 1 AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results |
ACELRX PHARMACEUTICALS INC
REDWOOD CITY, Calif, March 12, 2013-AcelRx Pharmaceuticals, Inc
| Unavailable | 3/13 | Unavailable |
|
| 2013 Coventry Health Care, Inc. Executive Management Incentive Plan |
COVENTRY HEALTH CARE INC
Coventry Health Care, Inc
| Unavailable | 3/13 | Unavailable |
|
| MEDICAL AESTHETICS VETERAN FREDERICK BEDDINGFIELD, III, MD, PHD APPOINTED NEW CHIEF MEDICAL OFFICER OF KYTHERA BIOPHARMACEUTICALS |
KYTHERA BIOPHARMACEUTICALS INC
Allergan, Inc
KYTHERA Biopharmaceuticals, Inc
| Unavailable | 3/13 | Unavailable |
|
| Acadia Healthcare Completes Offering of $150 Million Senior Unsecured Notes |
ACADIA HEALTHCARE COMPANY, INC.
Acadia Healthcare Company, Inc
| Unavailable | 3/13 | Unavailable |
|
| ACADIA PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2012 |
ACADIA PHARMACEUTICALS INC
ACADIA PHARMACEUTICALS REPORTS FINANCIAL
| Unavailable | 3/13 | Unavailable |
|
| Pernix Therapeutics Completes Acquisition of Somaxon Pharmaceuticals, Inc |
PERNIX THERAPEUTICS HOLDINGS, INC.
Pernix Therapeutics Holdings, Inc
Somaxon Pharmaceuticals, Inc
| Unavailable | 3/13 | Unavailable |
|
| PEREGRINE PHARMACEUTICALS REPORTS THIRD QUARTER FISCAL YEAR 2013 FINANCIAL RESULTS AND RECENT DEVELOPMENTS |
PEREGRINE PHARMACEUTICALS INC
PEREGRINE PHARMACEUTICALS REPORTS THIRD QUARTER FISCAL YEAR 2013 FINANCIAL
Peregrine Pharmaceuticals, Inc
| Unavailable | 3/13 | Unavailable |
|
| Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2012 Financial Results Keryx to Host Investor Conference Call Tomorrow, Tuesday, March 12, 2013 at 8:30am EST |
KERYX BIOPHARMACEUTICALS INC
Japan Tobacco Inc
Keryx Biopharmaceuticals, Inc
Torii Pharmaceutical Co, Ltd
| Unavailable | 3/13 | Unavailable |
|
| OMTHERA PHARMACEUTICALS 2010 STOCK OPTION PLAN |
OMTHERA PHARMACEUTICALS, INC.
Omthera Pharmaceuticals, Inc
| Unavailable | 3/13 | New York |
|